Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Organovo Holdings, Inc. (ONVO) Message Board

Scientific Origins The foundation of scaffold-fr

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 95
Posted On: 07/09/2013 6:28:05 PM
Avatar
Posted By: Badali

Scientific Origins


The foundation of scaffold-free bioprinting can be traced to the laboratory of our scientific founder, Professor Gabor Forgacs, at the University of Missouri–Columbia. A biophysicist with expertise in developmental biology, his pioneering observations in the study of wing development in chicks led to a desire to analyze and model the cell-cell interactions of embryology.


Dr. Forgacs and his academic partners demonstrated that mammalian cells could come together and form multicellular aggregates of a controlled shape and size, and that the interactions of these aggregates were governed by many of the same physical principles involved in interactions between drops of liquid. He leveraged this understanding to build the first prototype bioprinter that enabled precise placement of these cellular aggregates—also called bio-ink—to form simple ring and tubular structures that interacted with each other to yield intact tissues.


This was the first demonstration of directed assembly of three-dimensional tissues without dependency on integrated scaffolding or biomaterial components. Dr. Forgacs' unique discoveries were captured in a portfolio of patents and patent applications that are licensed exclusively to Organovo. An experienced team of scientists and engineers at Organovo and its partners have continued to advance 3D bioprinting technology as the NovoGen Bioprinter™ platform. Today, we are actively developing and commercializing 3D human tissues for various research and therapeutic applications.


http://www.organovo.com/science-technology/bi...ic-origins



(0)
(0)




Organovo Holdings, Inc. (ONVO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us